Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis

Published:2024-05 Issue: Volume: Page:
ISSN:1076-6332
Container-title:Academic Radiology
language:en
Short-container-title:Academic Radiology

Author:

Zhou Churen,Chang Boyang,Xiang Zhanwang,Li Zhengran,Wu Chun,Bai Mingjun,Jiang Zaibo,Huang Mingsheng,Chen Junwei^ORCID

Publisher

Elsevier BV

Reference24 articles.

1. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma;Singal;Hepatology,2023

2. European Association for the study of the liver. EASL clinical practice guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver;J Hepatol,2018

3. Hepatobiliary cancers, Version 2.2021, NCCN clinical practice guidelines in oncology;Benson;J Natl Compr Canc Netw,2021

4. The treatment of intermediate stage tumours beyond TACE: from surgery to systemic therapy;Galle;Journal of Hepatology,2017

5. BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system;Reig;The 2022 update. J Hepatol.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP